nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—psoriatic arthritis—Behcet's disease	0.181	0.203	CtDrD
Methotrexate—systemic scleroderma—Behcet's disease	0.175	0.195	CtDrD
Methotrexate—ankylosing spondylitis—Behcet's disease	0.149	0.167	CtDrD
Methotrexate—systemic lupus erythematosus—Behcet's disease	0.142	0.159	CtDrD
Methotrexate—rheumatoid arthritis—Behcet's disease	0.134	0.15	CtDrD
Methotrexate—psoriasis—Behcet's disease	0.113	0.126	CtDrD
Methotrexate—FOLR1—mouth—Behcet's disease	0.00225	0.0363	CbGeAlD
Methotrexate—SLC19A1—mouth—Behcet's disease	0.00197	0.0318	CbGeAlD
Methotrexate—SLC22A8—optic choroid—Behcet's disease	0.00183	0.0295	CbGeAlD
Methotrexate—MTHFR—artery—Behcet's disease	0.00145	0.0234	CbGeAlD
Methotrexate—FOLR1—eye—Behcet's disease	0.00143	0.0231	CbGeAlD
Methotrexate—MTHFR—blood vessel—Behcet's disease	0.00113	0.0182	CbGeAlD
Methotrexate—SLC46A1—eye—Behcet's disease	0.000965	0.0156	CbGeAlD
Methotrexate—ATIC—brainstem—Behcet's disease	0.000829	0.0134	CbGeAlD
Methotrexate—FPGS—retina—Behcet's disease	0.000827	0.0134	CbGeAlD
Methotrexate—GGH—skin of body—Behcet's disease	0.000826	0.0133	CbGeAlD
Methotrexate—ATIC—eye—Behcet's disease	0.000807	0.013	CbGeAlD
Methotrexate—ATIC—retina—Behcet's disease	0.0008	0.0129	CbGeAlD
Methotrexate—GGH—mammalian vulva—Behcet's disease	0.000753	0.0122	CbGeAlD
Methotrexate—FOLR1—central nervous system—Behcet's disease	0.00074	0.012	CbGeAlD
Methotrexate—FPGS—skin of body—Behcet's disease	0.000726	0.0117	CbGeAlD
Methotrexate—ATIC—skin of body—Behcet's disease	0.000702	0.0113	CbGeAlD
Methotrexate—GGH—medulla oblongata—Behcet's disease	0.00068	0.011	CbGeAlD
Methotrexate—SLC19A1—nervous system—Behcet's disease	0.000674	0.0109	CbGeAlD
Methotrexate—SLCO4C1—mammalian vulva—Behcet's disease	0.000668	0.0108	CbGeAlD
Methotrexate—FPGS—mammalian vulva—Behcet's disease	0.000662	0.0107	CbGeAlD
Methotrexate—SLC19A1—central nervous system—Behcet's disease	0.000649	0.0105	CbGeAlD
Methotrexate—FPGS—cardiac atrium—Behcet's disease	0.000634	0.0102	CbGeAlD
Methotrexate—GGH—midbrain—Behcet's disease	0.000621	0.01	CbGeAlD
Methotrexate—SLC46A1—spinal cord—Behcet's disease	0.000616	0.00996	CbGeAlD
Methotrexate—GGH—spinal cord—Behcet's disease	0.000606	0.0098	CbGeAlD
Methotrexate—MTHFR—eye—Behcet's disease	0.0006	0.00969	CbGeAlD
Methotrexate—FPGS—medulla oblongata—Behcet's disease	0.000598	0.00966	CbGeAlD
Methotrexate—FOLR1—brain—Behcet's disease	0.000588	0.0095	CbGeAlD
Methotrexate—SLCO3A1—retina—Behcet's disease	0.000585	0.00945	CbGeAlD
Methotrexate—DHFR—eye—Behcet's disease	0.000542	0.00876	CbGeAlD
Methotrexate—DHFR—retina—Behcet's disease	0.000537	0.00868	CbGeAlD
Methotrexate—FPGS—spinal cord—Behcet's disease	0.000533	0.00861	CbGeAlD
Methotrexate—ATIC—midbrain—Behcet's disease	0.000528	0.00854	CbGeAlD
Methotrexate—PGD—eye—Behcet's disease	0.000521	0.00842	CbGeAlD
Methotrexate—SLC46A1—nervous system—Behcet's disease	0.000519	0.00839	CbGeAlD
Methotrexate—PGD—retina—Behcet's disease	0.000516	0.00834	CbGeAlD
Methotrexate—ATIC—spinal cord—Behcet's disease	0.000515	0.00833	CbGeAlD
Methotrexate—SLC19A1—brain—Behcet's disease	0.000515	0.00833	CbGeAlD
Methotrexate—GGH—nervous system—Behcet's disease	0.000511	0.00826	CbGeAlD
Methotrexate—SLC46A1—central nervous system—Behcet's disease	0.0005	0.00808	CbGeAlD
Methotrexate—GGH—central nervous system—Behcet's disease	0.000492	0.00795	CbGeAlD
Methotrexate—SLC16A1—eye—Behcet's disease	0.000486	0.00786	CbGeAlD
Methotrexate—SLC16A1—retina—Behcet's disease	0.000482	0.00779	CbGeAlD
Methotrexate—TYMS—skin of body—Behcet's disease	0.000476	0.0077	CbGeAlD
Methotrexate—SLCO3A1—mammalian vulva—Behcet's disease	0.000468	0.00757	CbGeAlD
Methotrexate—AOX1—eye—Behcet's disease	0.000459	0.00742	CbGeAlD
Methotrexate—PGD—skin of body—Behcet's disease	0.000453	0.00733	CbGeAlD
Methotrexate—FPGS—nervous system—Behcet's disease	0.000449	0.00726	CbGeAlD
Methotrexate—SLCO3A1—cardiac atrium—Behcet's disease	0.000448	0.00725	CbGeAlD
Methotrexate—SLCO1C1—midbrain—Behcet's disease	0.000439	0.0071	CbGeAlD
Methotrexate—ATIC—nervous system—Behcet's disease	0.000434	0.00702	CbGeAlD
Methotrexate—TYMS—mammalian vulva—Behcet's disease	0.000434	0.00702	CbGeAlD
Methotrexate—FPGS—central nervous system—Behcet's disease	0.000432	0.00699	CbGeAlD
Methotrexate—DHFR—mammalian vulva—Behcet's disease	0.00043	0.00695	CbGeAlD
Methotrexate—SLCO1C1—spinal cord—Behcet's disease	0.000429	0.00693	CbGeAlD
Methotrexate—SLCO3A1—medulla oblongata—Behcet's disease	0.000423	0.00683	CbGeAlD
Methotrexate—ATIC—central nervous system—Behcet's disease	0.000418	0.00676	CbGeAlD
Methotrexate—PGD—mammalian vulva—Behcet's disease	0.000413	0.00668	CbGeAlD
Methotrexate—DHFR—cardiac atrium—Behcet's disease	0.000412	0.00666	CbGeAlD
Methotrexate—SLC46A1—brain—Behcet's disease	0.000397	0.00641	CbGeAlD
Methotrexate—PGD—cardiac atrium—Behcet's disease	0.000396	0.0064	CbGeAlD
Methotrexate—GGH—brain—Behcet's disease	0.00039	0.00631	CbGeAlD
Methotrexate—DHFR—medulla oblongata—Behcet's disease	0.000388	0.00627	CbGeAlD
Methotrexate—SLCO3A1—midbrain—Behcet's disease	0.000386	0.00624	CbGeAlD
Methotrexate—SLCO3A1—spinal cord—Behcet's disease	0.000377	0.00609	CbGeAlD
Methotrexate—PGD—medulla oblongata—Behcet's disease	0.000373	0.00603	CbGeAlD
Methotrexate—SLC16A1—cardiac atrium—Behcet's disease	0.00037	0.00597	CbGeAlD
Methotrexate—SLC22A8—eye—Behcet's disease	0.000368	0.00594	CbGeAlD
Methotrexate—AOX1—mammalian vulva—Behcet's disease	0.000364	0.00589	CbGeAlD
Methotrexate—SLCO1C1—nervous system—Behcet's disease	0.000361	0.00584	CbGeAlD
Methotrexate—TYMS—midbrain—Behcet's disease	0.000358	0.00579	CbGeAlD
Methotrexate—DHFR—midbrain—Behcet's disease	0.000355	0.00573	CbGeAlD
Methotrexate—ABCC10—mammalian vulva—Behcet's disease	0.000354	0.00573	CbGeAlD
Methotrexate—AOX1—cardiac atrium—Behcet's disease	0.000349	0.00564	CbGeAlD
Methotrexate—SLC16A1—medulla oblongata—Behcet's disease	0.000348	0.00563	CbGeAlD
Methotrexate—SLCO1C1—central nervous system—Behcet's disease	0.000348	0.00562	CbGeAlD
Methotrexate—DHFR—spinal cord—Behcet's disease	0.000346	0.00559	CbGeAlD
Methotrexate—FPGS—brain—Behcet's disease	0.000343	0.00555	CbGeAlD
Methotrexate—PGD—midbrain—Behcet's disease	0.000341	0.00551	CbGeAlD
Methotrexate—ABCC10—cardiac atrium—Behcet's disease	0.000339	0.00549	CbGeAlD
Methotrexate—PGD—spinal cord—Behcet's disease	0.000333	0.00538	CbGeAlD
Methotrexate—ATIC—brain—Behcet's disease	0.000332	0.00537	CbGeAlD
Methotrexate—MTHFR—nervous system—Behcet's disease	0.000323	0.00522	CbGeAlD
Methotrexate—ABCC10—medulla oblongata—Behcet's disease	0.00032	0.00517	CbGeAlD
Methotrexate—SLC16A1—midbrain—Behcet's disease	0.000318	0.00515	CbGeAlD
Methotrexate—SLCO3A1—nervous system—Behcet's disease	0.000318	0.00513	CbGeAlD
Methotrexate—MTHFR—central nervous system—Behcet's disease	0.000311	0.00502	CbGeAlD
Methotrexate—SLC16A1—spinal cord—Behcet's disease	0.000311	0.00502	CbGeAlD
Methotrexate—SLCO3A1—central nervous system—Behcet's disease	0.000306	0.00494	CbGeAlD
Methotrexate—TYMS—nervous system—Behcet's disease	0.000295	0.00476	CbGeAlD
Methotrexate—ABCC10—midbrain—Behcet's disease	0.000292	0.00473	CbGeAlD
Methotrexate—DHFR—nervous system—Behcet's disease	0.000292	0.00471	CbGeAlD
Methotrexate—MTHFR—Selenium Micronutrient Network—APOB—Behcet's disease	0.000286	0.00647	CbGpPWpGaD
Methotrexate—ALB—Scavenging of heme from plasma—APOA1—Behcet's disease	0.000286	0.00645	CbGpPWpGaD
Methotrexate—ABCC10—spinal cord—Behcet's disease	0.000285	0.00461	CbGeAlD
Methotrexate—MTHFR—Folate Metabolism—APOA1—Behcet's disease	0.000285	0.00644	CbGpPWpGaD
Methotrexate—TYMS—central nervous system—Behcet's disease	0.000284	0.00458	CbGeAlD
Methotrexate—DHFR—central nervous system—Behcet's disease	0.000281	0.00454	CbGeAlD
Methotrexate—PGD—nervous system—Behcet's disease	0.00028	0.00453	CbGeAlD
Methotrexate—ABCC4—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.00028	0.00631	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.000278	0.00628	CbGpPWpGaD
Methotrexate—SLCO1C1—brain—Behcet's disease	0.000276	0.00446	CbGeAlD
Methotrexate—SLCO1A2—medulla oblongata—Behcet's disease	0.000276	0.00446	CbGeAlD
Methotrexate—MTHFR—Folate Metabolism—ICAM1—Behcet's disease	0.000271	0.00612	CbGpPWpGaD
Methotrexate—PGD—central nervous system—Behcet's disease	0.00027	0.00436	CbGeAlD
Methotrexate—SLC16A1—nervous system—Behcet's disease	0.000262	0.00423	CbGeAlD
Methotrexate—SLC22A7—brain—Behcet's disease	0.000262	0.00423	CbGeAlD
Methotrexate—ALB—HDL-mediated lipid transport—APOA1—Behcet's disease	0.000255	0.00575	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—APOA1—Behcet's disease	0.000254	0.00572	CbGpPWpGaD
Methotrexate—SLC22A6—brain—Behcet's disease	0.000253	0.00408	CbGeAlD
Methotrexate—SLCO1A2—midbrain—Behcet's disease	0.000252	0.00407	CbGeAlD
Methotrexate—SLC16A1—central nervous system—Behcet's disease	0.000252	0.00407	CbGeAlD
Methotrexate—TYMS—Nucleotide metabolism—CAT—Behcet's disease	0.000252	0.00569	CbGpPWpGaD
Methotrexate—ABCC1—mammalian vulva—Behcet's disease	0.000251	0.00405	CbGeAlD
Methotrexate—MTHFR—brain—Behcet's disease	0.000247	0.00399	CbGeAlD
Methotrexate—SLCO1A2—spinal cord—Behcet's disease	0.000246	0.00398	CbGeAlD
Methotrexate—SLCO3A1—brain—Behcet's disease	0.000243	0.00392	CbGeAlD
Methotrexate—ABCB1—blood vessel—Behcet's disease	0.000242	0.00392	CbGeAlD
Methotrexate—ABCC3—nervous system—Behcet's disease	0.000242	0.00391	CbGeAlD
Methotrexate—DHFR—Folate Metabolism—ICAM1—Behcet's disease	0.000241	0.00544	CbGpPWpGaD
Methotrexate—ABCC1—cardiac atrium—Behcet's disease	0.00024	0.00388	CbGeAlD
Methotrexate—ABCC2—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000236	0.00532	CbGpPWpGaD
Methotrexate—ABCC1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000233	0.00526	CbGpPWpGaD
Methotrexate—ABCC3—central nervous system—Behcet's disease	0.000233	0.00376	CbGeAlD
Methotrexate—MTHFR—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000227	0.00512	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—SERPINE1—Behcet's disease	0.000226	0.00511	CbGpPWpGaD
Methotrexate—TYMS—brain—Behcet's disease	0.000225	0.00364	CbGeAlD
Methotrexate—DHFR—brain—Behcet's disease	0.000223	0.0036	CbGeAlD
Methotrexate—SLC46A1—Folate Metabolism—TNF—Behcet's disease	0.000221	0.00499	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000215	0.00486	CbGpPWpGaD
Methotrexate—PGD—brain—Behcet's disease	0.000214	0.00346	CbGeAlD
Methotrexate—SLC16A1—Cell surface interactions at the vascular wall—APOB—Behcet's disease	0.000211	0.00476	CbGpPWpGaD
Methotrexate—ABCG2—mammalian vulva—Behcet's disease	0.000208	0.00335	CbGeAlD
Methotrexate—SLCO1A2—nervous system—Behcet's disease	0.000207	0.00335	CbGeAlD
Methotrexate—DHFR—Folate Metabolism—SERPINE1—Behcet's disease	0.000201	0.00454	CbGpPWpGaD
Methotrexate—SLC16A1—brain—Behcet's disease	0.0002	0.00323	CbGeAlD
Methotrexate—SLCO1A2—central nervous system—Behcet's disease	0.0002	0.00322	CbGeAlD
Methotrexate—ABCC4—nervous system—Behcet's disease	0.000199	0.00322	CbGeAlD
Methotrexate—SLC22A8—nervous system—Behcet's disease	0.000198	0.0032	CbGeAlD
Methotrexate—ABCC4—central nervous system—Behcet's disease	0.000192	0.0031	CbGeAlD
Methotrexate—SLC22A8—central nervous system—Behcet's disease	0.00019	0.00308	CbGeAlD
Methotrexate—AOX1—brain—Behcet's disease	0.000189	0.00305	CbGeAlD
Methotrexate—ABCG2—medulla oblongata—Behcet's disease	0.000187	0.00303	CbGeAlD
Methotrexate—DHFR—E2F transcription factor network—SERPINE1—Behcet's disease	0.000186	0.00419	CbGpPWpGaD
Methotrexate—ALB—Lipoprotein metabolism—APOB—Behcet's disease	0.000185	0.00418	CbGpPWpGaD
Methotrexate—ABCC3—brain—Behcet's disease	0.000185	0.00298	CbGeAlD
Methotrexate—ABCC10—brain—Behcet's disease	0.000184	0.00297	CbGeAlD
Methotrexate—MTHFR—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.00018	0.00406	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.000174	0.00392	CbGpPWpGaD
Methotrexate—ABCG2—midbrain—Behcet's disease	0.000171	0.00277	CbGeAlD
Methotrexate—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—Behcet's disease	0.00017	0.00385	CbGpPWpGaD
Methotrexate—ABCG2—spinal cord—Behcet's disease	0.000167	0.0027	CbGeAlD
Methotrexate—MTHFR—Vitamin B12 Metabolism—TNF—Behcet's disease	0.000164	0.0037	CbGpPWpGaD
Methotrexate—TYMS—E2F transcription factor network—SERPINE1—Behcet's disease	0.000162	0.00366	CbGpPWpGaD
Methotrexate—SLCO1A2—brain—Behcet's disease	0.000158	0.00256	CbGeAlD
Methotrexate—ALB—brain—Behcet's disease	0.000157	0.00255	CbGeAlD
Methotrexate—ABCC11—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000153	0.00346	CbGpPWpGaD
Methotrexate—ABCC4—brain—Behcet's disease	0.000152	0.00246	CbGeAlD
Methotrexate—SLC22A8—brain—Behcet's disease	0.000151	0.00244	CbGeAlD
Methotrexate—ABCC4—Platelet degranulation—APOA1—Behcet's disease	0.000148	0.00333	CbGpPWpGaD
Methotrexate—ALB—Lipoprotein metabolism—APOA1—Behcet's disease	0.000146	0.0033	CbGpPWpGaD
Methotrexate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOB—Behcet's disease	0.000144	0.00325	CbGpPWpGaD
Methotrexate—ABCC4—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.000141	0.00317	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—TNF—Behcet's disease	0.000134	0.00301	CbGpPWpGaD
Methotrexate—ABCC1—brain—Behcet's disease	0.00013	0.0021	CbGeAlD
Methotrexate—ABCB1—retina—Behcet's disease	0.000128	0.00207	CbGeAlD
Methotrexate—ALB—Lipid and lipoprotein metabolism—APOB—Behcet's disease	0.000123	0.00277	CbGpPWpGaD
Methotrexate—ABCC11—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000121	0.00273	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—APOB—Behcet's disease	0.000121	0.00273	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—TNF—Behcet's disease	0.000119	0.00268	CbGpPWpGaD
Methotrexate—ABCC4—Platelet degranulation—SERPINE1—Behcet's disease	0.000117	0.00264	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—ITGB2—Behcet's disease	0.000115	0.0026	CbGpPWpGaD
Methotrexate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—Behcet's disease	0.000114	0.00257	CbGpPWpGaD
Methotrexate—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.000112	0.00252	CbGpPWpGaD
Methotrexate—ABCB1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000111	0.0025	CbGpPWpGaD
Methotrexate—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—Behcet's disease	0.000108	0.00243	CbGpPWpGaD
Methotrexate—ABCG2—brain—Behcet's disease	0.000108	0.00174	CbGeAlD
Methotrexate—MTHFR—Selenium Micronutrient Network—TNF—Behcet's disease	0.000106	0.00239	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—ITGAL—Behcet's disease	0.000104	0.00235	CbGpPWpGaD
Methotrexate—ABCB1—mammalian vulva—Behcet's disease	0.000102	0.00165	CbGeAlD
Methotrexate—ALB—Folate Metabolism—CAT—Behcet's disease	0.000101	0.00229	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000101	0.00229	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000101	0.00229	CbGpPWpGaD
Methotrexate—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.0001	0.00226	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—APOB—Behcet's disease	9.85e-05	0.00222	CbGpPWpGaD
Methotrexate—ALB—Lipid and lipoprotein metabolism—APOA1—Behcet's disease	9.73e-05	0.0022	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—APOB—Behcet's disease	9.61e-05	0.00217	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—APOA1—Behcet's disease	9.57e-05	0.00216	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—CTLA4—Behcet's disease	9.35e-05	0.00211	CbGpPWpGaD
Methotrexate—ABCB1—medulla oblongata—Behcet's disease	9.24e-05	0.00149	CbGeAlD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—APOB—Behcet's disease	9.17e-05	0.00207	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—ICAM1—Behcet's disease	9.1e-05	0.00205	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ITGB2—Behcet's disease	8.6e-05	0.00194	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—APOB—Behcet's disease	8.56e-05	0.00193	CbGpPWpGaD
Methotrexate—ABCB1—midbrain—Behcet's disease	8.44e-05	0.00136	CbGeAlD
Methotrexate—ABCB1—spinal cord—Behcet's disease	8.24e-05	0.00133	CbGeAlD
Methotrexate—ALB—Selenium Micronutrient Network—CAT—Behcet's disease	8.06e-05	0.00182	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—APOA1—Behcet's disease	8.02e-05	0.00181	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—APOA1—Behcet's disease	8.02e-05	0.00181	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—APOB—Behcet's disease	7.82e-05	0.00177	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—APOA1—Behcet's disease	7.79e-05	0.00176	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ITGAL—Behcet's disease	7.75e-05	0.00175	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—APOB—Behcet's disease	7.69e-05	0.00173	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—APOA1—Behcet's disease	7.61e-05	0.00172	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	7.6e-05	0.00172	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—ICAM1—Behcet's disease	7.4e-05	0.00167	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—CAT—Behcet's disease	7.39e-05	0.00167	CbGpPWpGaD
Methotrexate—FPGS—Disease—APOB—Behcet's disease	7.28e-05	0.00164	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL10—Behcet's disease	7.27e-05	0.00164	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—APOA1—Behcet's disease	7.26e-05	0.00164	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—SERPINE1—Behcet's disease	7.2e-05	0.00163	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—APOB—Behcet's disease	7.17e-05	0.00162	CbGpPWpGaD
Methotrexate—ABCB1—nervous system—Behcet's disease	6.94e-05	0.00112	CbGeAlD
Methotrexate—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	6.91e-05	0.00156	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—APOA1—Behcet's disease	6.77e-05	0.00153	CbGpPWpGaD
Methotrexate—ABCB1—central nervous system—Behcet's disease	6.68e-05	0.00108	CbGeAlD
Methotrexate—ALB—Platelet degranulation—APOA1—Behcet's disease	6.68e-05	0.00151	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	6.55e-05	0.00148	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	6.36e-05	0.00144	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—CAT—Behcet's disease	6.28e-05	0.00142	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—CAT—Behcet's disease	6.28e-05	0.00142	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—APOA1—Behcet's disease	6.19e-05	0.0014	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—SERPINE1—Behcet's disease	6.18e-05	0.0014	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—APOB—Behcet's disease	6.1e-05	0.00138	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—APOB—Behcet's disease	6.1e-05	0.00138	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—APOA1—Behcet's disease	6.08e-05	0.00137	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—ICAM1—Behcet's disease	5.88e-05	0.00133	CbGpPWpGaD
Methotrexate—FPGS—Disease—APOA1—Behcet's disease	5.76e-05	0.0013	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—APOB—Behcet's disease	5.72e-05	0.00129	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—APOA1—Behcet's disease	5.67e-05	0.00128	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—APOB—Behcet's disease	5.67e-05	0.00128	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	5.42e-05	0.00122	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—SERPINE1—Behcet's disease	5.38e-05	0.00121	CbGpPWpGaD
Methotrexate—ABCB1—brain—Behcet's disease	5.31e-05	0.000858	CbGeAlD
Methotrexate—ALB—Platelet degranulation—SERPINE1—Behcet's disease	5.3e-05	0.0012	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	5.2e-05	0.00117	CbGpPWpGaD
Methotrexate—PGD—Disease—APOB—Behcet's disease	5.19e-05	0.00117	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NOS3—Behcet's disease	5.13e-05	0.00116	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	5.05e-05	0.00114	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—APOB—Behcet's disease	5.05e-05	0.00114	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—APOB—Behcet's disease	4.95e-05	0.00112	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—SERPINE1—Behcet's disease	4.91e-05	0.00111	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CAT—Behcet's disease	4.89e-05	0.0011	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—APOA1—Behcet's disease	4.82e-05	0.00109	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—APOA1—Behcet's disease	4.82e-05	0.00109	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—APOB—Behcet's disease	4.75e-05	0.00107	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—APOB—Behcet's disease	4.58e-05	0.00103	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.58e-05	0.00103	CbGpPWpGaD
Methotrexate—FPGS—Disease—SERPINE1—Behcet's disease	4.57e-05	0.00103	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—APOA1—Behcet's disease	4.53e-05	0.00102	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—APOA1—Behcet's disease	4.49e-05	0.00101	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—TNF—Behcet's disease	4.48e-05	0.00101	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CAT—Behcet's disease	4.47e-05	0.00101	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	4.42e-05	0.000998	CbGpPWpGaD
Methotrexate—FPGS—Disease—NOS3—Behcet's disease	4.36e-05	0.000985	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—APOB—Behcet's disease	4.35e-05	0.000982	CbGpPWpGaD
Methotrexate—PGD—Metabolism—APOB—Behcet's disease	4.34e-05	0.00098	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—NOS3—Behcet's disease	4.3e-05	0.00097	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—APOB—Behcet's disease	4.27e-05	0.000963	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.13e-05	0.000932	CbGpPWpGaD
Methotrexate—PGD—Disease—APOA1—Behcet's disease	4.1e-05	0.000926	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—APOA1—Behcet's disease	4e-05	0.000902	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	3.97e-05	0.000897	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—APOB—Behcet's disease	3.93e-05	0.000886	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.92e-05	0.000884	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ITGB2—Behcet's disease	3.89e-05	0.000878	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—APOB—Behcet's disease	3.85e-05	0.000869	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—APOA1—Behcet's disease	3.76e-05	0.000848	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—APOB—Behcet's disease	3.69e-05	0.000833	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—NOS3—Behcet's disease	3.66e-05	0.000825	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—NOS3—Behcet's disease	3.66e-05	0.000825	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—Behcet's disease	3.65e-05	0.000823	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.63e-05	0.000818	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.62e-05	0.000817	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	3.6e-05	0.000812	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—SERPINE1—Behcet's disease	3.59e-05	0.000811	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—SERPINE1—Behcet's disease	3.56e-05	0.000804	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ITGAL—Behcet's disease	3.51e-05	0.000792	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.44e-05	0.000777	CbGpPWpGaD
Methotrexate—PGD—Metabolism—APOA1—Behcet's disease	3.44e-05	0.000776	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NOS3—Behcet's disease	3.43e-05	0.000774	CbGpPWpGaD
Methotrexate—MTHFR—Disease—APOB—Behcet's disease	3.42e-05	0.000772	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—APOB—Behcet's disease	3.42e-05	0.000772	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS3—Behcet's disease	3.4e-05	0.000768	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—APOA1—Behcet's disease	3.37e-05	0.000762	CbGpPWpGaD
Methotrexate—AOX1—Disease—APOB—Behcet's disease	3.34e-05	0.000754	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.27e-05	0.000738	CbGpPWpGaD
Methotrexate—PGD—Disease—SERPINE1—Behcet's disease	3.26e-05	0.000735	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	3.24e-05	0.00073	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—APOB—Behcet's disease	3.21e-05	0.000725	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—APOB—Behcet's disease	3.11e-05	0.000703	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS3—Behcet's disease	3.11e-05	0.000702	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.11e-05	0.000701	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—APOB—Behcet's disease	3.08e-05	0.000695	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	3.08e-05	0.000694	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.05e-05	0.000688	CbGpPWpGaD
Methotrexate—DHFR—Disease—APOB—Behcet's disease	3.04e-05	0.000686	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	2.96e-05	0.000669	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CAT—Behcet's disease	2.95e-05	0.000666	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—APOB—Behcet's disease	2.92e-05	0.00066	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.92e-05	0.000659	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—Behcet's disease	2.9e-05	0.000654	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CAT—Behcet's disease	2.88e-05	0.000651	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—APOB—Behcet's disease	2.87e-05	0.000647	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NOS3—Behcet's disease	2.85e-05	0.000643	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	2.85e-05	0.000642	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—APOB—Behcet's disease	2.8e-05	0.000632	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—Behcet's disease	2.77e-05	0.000624	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	2.71e-05	0.000611	CbGpPWpGaD
Methotrexate—MTHFR—Disease—APOA1—Behcet's disease	2.71e-05	0.000611	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.71e-05	0.000611	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—SERPINE1—Behcet's disease	2.68e-05	0.000605	CbGpPWpGaD
Methotrexate—AOX1—Disease—APOA1—Behcet's disease	2.64e-05	0.000597	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CAT—Behcet's disease	2.62e-05	0.000592	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NOS3—Behcet's disease	2.6e-05	0.000588	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	2.56e-05	0.000578	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS3—Behcet's disease	2.56e-05	0.000577	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—APOB—Behcet's disease	2.55e-05	0.000575	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.54e-05	0.000574	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.46e-05	0.000556	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.43e-05	0.000549	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	2.43e-05	0.000549	CbGpPWpGaD
Methotrexate—DHFR—Disease—APOA1—Behcet's disease	2.41e-05	0.000543	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CAT—Behcet's disease	2.39e-05	0.000539	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	2.35e-05	0.000531	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—APOB—Behcet's disease	2.32e-05	0.000524	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.31e-05	0.000522	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CAT—Behcet's disease	2.29e-05	0.000517	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—APOA1—Behcet's disease	2.27e-05	0.000512	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—APOB—Behcet's disease	2.22e-05	0.000502	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—APOA1—Behcet's disease	2.21e-05	0.0005	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SERPINE1—Behcet's disease	2.15e-05	0.000485	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.14e-05	0.000484	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CAT—Behcet's disease	2.1e-05	0.000474	CbGpPWpGaD
Methotrexate—AOX1—Disease—SERPINE1—Behcet's disease	2.1e-05	0.000474	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS3—Behcet's disease	2.05e-05	0.000463	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOB—Behcet's disease	2.04e-05	0.00046	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—APOA1—Behcet's disease	2.01e-05	0.000455	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS3—Behcet's disease	2e-05	0.000452	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—APOB—Behcet's disease	1.93e-05	0.000436	CbGpPWpGaD
Methotrexate—DHFR—Disease—SERPINE1—Behcet's disease	1.91e-05	0.000431	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CAT—Behcet's disease	1.89e-05	0.000428	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOB—Behcet's disease	1.84e-05	0.000415	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—APOA1—Behcet's disease	1.84e-05	0.000414	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—Behcet's disease	1.82e-05	0.000412	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—APOA1—Behcet's disease	1.76e-05	0.000397	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	1.76e-05	0.000397	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOB—Behcet's disease	1.72e-05	0.000388	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—Behcet's disease	1.72e-05	0.000388	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—Behcet's disease	1.68e-05	0.000379	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—APOB—Behcet's disease	1.67e-05	0.000377	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CAT—Behcet's disease	1.65e-05	0.000372	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOA1—Behcet's disease	1.61e-05	0.000364	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOB—Behcet's disease	1.6e-05	0.000361	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—APOA1—Behcet's disease	1.53e-05	0.000345	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—Behcet's disease	1.53e-05	0.000345	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CAT—Behcet's disease	1.48e-05	0.000335	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	1.46e-05	0.00033	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOA1—Behcet's disease	1.46e-05	0.000328	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOB—Behcet's disease	1.44e-05	0.000325	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CAT—Behcet's disease	1.41e-05	0.000318	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—Behcet's disease	1.39e-05	0.000314	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	1.39e-05	0.000314	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOB—Behcet's disease	1.37e-05	0.000309	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	1.37e-05	0.000308	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOA1—Behcet's disease	1.36e-05	0.000307	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—Behcet's disease	1.33e-05	0.000301	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—APOA1—Behcet's disease	1.32e-05	0.000298	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CAT—Behcet's disease	1.31e-05	0.000295	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOB—Behcet's disease	1.27e-05	0.000286	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOA1—Behcet's disease	1.27e-05	0.000286	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—Behcet's disease	1.22e-05	0.000276	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINE1—Behcet's disease	1.21e-05	0.000274	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	1.16e-05	0.000261	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—Behcet's disease	1.16e-05	0.000261	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOA1—Behcet's disease	1.14e-05	0.000257	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—Behcet's disease	1.1e-05	0.000249	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOA1—Behcet's disease	1.08e-05	0.000245	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SERPINE1—Behcet's disease	1.08e-05	0.000244	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—Behcet's disease	1.03e-05	0.000233	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOA1—Behcet's disease	1e-05	0.000226	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—Behcet's disease	9.6e-06	0.000217	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—Behcet's disease	8.64e-06	0.000195	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—Behcet's disease	8.21e-06	0.000185	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CAT—Behcet's disease	8.06e-06	0.000182	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOB—Behcet's disease	7.83e-06	0.000177	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—Behcet's disease	7.6e-06	0.000172	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CAT—Behcet's disease	7.06e-06	0.000159	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOB—Behcet's disease	6.86e-06	0.000155	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOA1—Behcet's disease	6.19e-06	0.00014	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOA1—Behcet's disease	5.42e-06	0.000122	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—Behcet's disease	4.69e-06	0.000106	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—Behcet's disease	4.11e-06	9.28e-05	CbGpPWpGaD
